Watchlist Price Alert

Eliem Therapeutics Inc. (ELYM)

NASDAQ: ELYM · Real-Time Price · USD

5.11

-0.05 (-0.97%)

At close: Oct 02, 2024, 8:00 PM

Eliem Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-35.12M	-45.24M	-47.48M	-20.67M	-6.55M
Depreciation & Amortization	n/a	n/a	1.84M	n/a	n/a
Stock-Based Compensation	12.81M	6.99M	3.74M	707K	n/a
Other Working Capital	4.45M	863K	-4.32M	-2.91M	-326K
Other Non-Cash Items	-2.05M	2.06M	11.84M	8.8M	1.85M
Deferred Income Tax	n/a	-1.39M	-1.84M	n/a	n/a
Change in Working Capital	3.76M	210K	-4.17M	-2.94M	-309K
Operating Cash Flow	-20.6M	-37.37M	-36.07M	-14.1M	-5.01M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	8.28K	n/a
Purchase of Investments	-58.45M	-87.96M	-114.97M	n/a	n/a
Sales Maturities Of Investments	127.43M	122.4M	n/a	n/a	n/a
Other Investing Acitivies	68.98K	34.44K	-114.97K	8.07M	n/a
Investing Cash Flow	68.98M	34.44M	-114.97M	8.08M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	841K	n/a	149K	n/a	n/a
Financial Cash Flow	841K	n/a	177.23M	4.92M	26.24M
Net Cash Flow	49.53M	-3.34M	26.43M	-736K	21.22M
Free Cash Flow	-20.6M	-37.37M	-36.07M	-14.1M	-5.01M